openPR Logo
Press release

Connected Drug Delivery Devices Market Business Opportunity and Application Analysis 2027 Phillips-Medisize , West Pharma, Aterica, Panasonic Corporation, BIOCORP, Merck KGaA, Propeller Health, Proteus Digital Health, Adherium Limited, and Qualcomm Techno

01-29-2019 04:35 PM CET | Health & Medicine

Press release from: The Insight Partners

Connected Drug Delivery Devices Market

Connected Drug Delivery Devices Market

The research report evaluates the Connected Drug Delivery Devices Market in an all-inclusive manner by explaining the prime characteristics of the market that is likely to have a quantifiable influence on its progressive scenarios over the forecast period.

Many drug delivery device manufacturer are combining their medical devices or drug-delivery systems with connected capabilities like Bluetooth, Near Field Communication (NFC), and other technologies to boost patient compliance and innovate new products. Thus, connected drug delivery devices are game changers in therapeutics.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global connected drug delivery devices market based on product, technology and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The connected drug delivery devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

Get PDF Sample Copy of Research Report: https://bit.ly/2HEQLo9

North America is expected to contribute to the largest share in the connected drug delivery devices market in the forecast period, due to presence of large number of market players in the U.S. and growing efforts by the key market players to enhance their product portfolio, rapid adoption of latest medical technologies and devices, high per capita healthcare expenditure, and growing awareness regarding the side effects of non-adherence to medication. However, Asia Pacific region is expected to be the fastest growing region owing to the increasing incidences of chronic diseases, large patient population, and rising per capita animal health expenditure in this region and increased preference for smart technology devices by the patients drives the market growth in this region.

The report analyzes factors affecting connected drug delivery devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the connected drug delivery devices market in these regions.

The report also includes the profiles of key companies providing connected drug delivery devices along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the connected drug delivery devices market include, Phillips-Medisize , West Pharma, Aterica Inc. , Panasonic Corporation, BIOCORP, Merck KGaA, Propeller Health, Proteus Digital Health, Adherium Limited, and Qualcomm Technologies, Inc. among others.

Order a Copy of this research at https://bit.ly/2CR9S8F

Global Connected Drug Delivery Devices Market - By Geography

North America
U.S.
Canada
Mexico

Europe
UK
Germany
France

Asia Pacific (APAC)
Japan
China
India

Middle East & Africa (MEA)
U.A.E
Saudi Arabia
South Africa

South and Central America (SCAM)
Brazil

The connected drug delivery devices market is anticipated to grow during the forecast period owing to key factors such as growing patient connectivity and engagement, and increasing patient awareness about adherence to prescribed therapies. However, high cost of such devices and the concern of cybersecurity restrain the growth of the market.

Similar reports: Implantable Drug Delivery Devices Market to 2025 – Global Analysis and Forecasts by Product (Capsule Endoscopy, Drug Delivery, Patient Monitoring) By Type (Gastrointestinal Diseases, Neurological Disorders, Cancer, Inherited Disorders, and Other Indications) and By Technology (Smart Pill Technology (SPT), Microfluidics, Fabrication Technology) and Application (Cardiology, Ophthalmology, Contraception, Oncology and Others)

Get PDF sample copy@ https://www.theinsightpartners.com/sample/TIPHE100001267/?nbo

About Us
The Insight Partners Is A One Stop Industry Research Provider Of Actionable Intelligence. We Help Our Clients In Getting Solutions To Their Research Requirements Through Our Syndicated And Consulting Research Services.
We Are Committed To Providing Highest Quality Research And Consulting Services To Our Customers. We Help Our Clients Understand Key Market Trends, Identify Opportunities, And Make Informed Decisions By Providing Market Research Solutions At An Affordable Cost.

The Insight Partners,
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: http://www.theinsightpartners.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Connected Drug Delivery Devices Market Business Opportunity and Application Analysis 2027 Phillips-Medisize , West Pharma, Aterica, Panasonic Corporation, BIOCORP, Merck KGaA, Propeller Health, Proteus Digital Health, Adherium Limited, and Qualcomm Techno here

News-ID: 1543039 • Views:

More Releases from The Insight Partners

Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
Orthopedic 3D Scanners Market Is Gaining Huge Growth In Upcoming Years
3D orthopaedic scanning devices are sophisticated technology-driven systems used to scan human body components for the detection and treatment of the defect. By means of its scanning capabilities, 3D orthopaedic scanning systems help to design uniquely customised products and to find further use in surgical procedures. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00017457/?utm_source=OpenPR&utm_medium=10129 Orthopedic 3D Scanners Market: Competitive Landscape and Key Developments: • Delcam Plc • Allied OSI Labs • SCANNY3D S.r.l. • AGE Solutions S.r.l. • Orthopaedic Innovation Centre • Diasu
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate Cancer Diagnostics: A Guide to Understanding the Process
Prostate cancer diagnostics refers to the various tests and procedures used to diagnose prostate cancer in men. Early detection of prostate cancer is important for successful treatment and recovery. Several different diagnostic tests are available, including digital rectal exams, prostate-specific antigen (PSA) tests, and biopsies. With the increasing prevalence of prostate cancer. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003656/?utm_source=OpenPR&utm_medium=10129 Prostate Cancer Diagnostics Market: Competitive Landscape and Key Developments: • MDxHealth • Telo Genomics Corp
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031
Aerospace Plastics Market Research Insights with Upcoming Trends Segmentation, O …
The Aerospace Plastics Market report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation. Get Sample Copy of Report at: https://www.theinsightpartners.com/sample/TIPRE00005464/?utm_source=OpenPR&utm_medium=10188 Companies Profiled in this report includes: • SABIC • Victrex • Drake Plastics Ltd • Solvay • BASF SE • Evonik Industries AG • Vantage Plane Plastics • Paco Plastics & Engineering Inc. • 3P • Performance Plastics Products • Big Bear Plastics The report scrutinizes different business approaches and frameworks that
Consumer Genomics: A Guide to Understanding the Process
Consumer Genomics: A Guide to Understanding the Process
Consumer genomics market is growing as it is very frictionless. A patient can purchase a genetic test online and then receive a test kit by mail and collect a DNA sample in their own home. Patients will receive the results at home and don't need any guidance of a genetic counselor or medical practitioner. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00006429/?utm_source=OpenPR&utm_medium=10129 Consumer Genomics Market: Competitive Landscape and Key Developments: •

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug